This Week in Pediatrics
Pediatricians group finds kids of all ages need regular recess for physical and mental health
PUBLISHED: May 11, 2026 at 6:30 AM PDT | UPDATED: May 11, 2026 at 6:40 AM PDT · Getting your Trinity Audio player ready... By LAURA UNGAR, AP Medical Writer · Recess isn’t just a fun break for grade schoolers. It’s crucial to good health and good grades for kids of all ages. That...
Pediatricians group finds kids of all ages need regular recess for physical and mental health
It’s crucial to good health and good grades for kids of all ages. That's the message from a leading pediatricians group, which just released the first new guidance in 13 years about this unstructured time at school and how it needs to be protected. The updated policy stateme...
Pediatrics group issues new guidance on recess for the first time in 13 years | CNN
It’s crucial to good health and good grades for kids of all ages. That’s the message from a leading pediatricians group, which just released the first new guidance in 13 years about this unstructured time at school and how it needs to be protected. The updated policy statement by...
Research of the Day
Delayed Epinephrine Administration in Pediatric Anaphylaxis: Multi-Center Analysis
This multi-center retrospective study analyzed 2,800 pediatric anaphylaxis cases across 12 children's hospitals. Delayed epinephrine administration (>15 minutes from symptom onset) occurred in 42% of cases and was associated with increased risk of severe outcomes and biphasic reactions.
Key findings: (1) Delayed epinephrine associated with 3.2x increased odds of hospitalization; (2) Food-induced reactions most likely to have delayed treatment; (3) Many families cited fear of injection or uncertainty about symptoms as reasons for delay.
Reinforce epinephrine-first messaging for anaphylaxis. Ensure families can recognize symptoms and use auto-injectors confidently. Consider demonstration at every visit for patients with prescribed epinephrine.
Popular Beliefs
Letting babies walk early causes bowlegs
What the evidence shows: There is no evidence that early walking causes bowlegs. Most infants have some degree of bowing that typically resolves by age 3-4. Pathologic bowing has other causes (Blount disease, rickets). Encourage normal motor development and monitor for asymmetric or progressive bowing.
Too many vaccines overwhelm a child's immune system
What the evidence shows: Children's immune systems handle vastly more antigens daily from the environment than from vaccines. Today's vaccines contain far fewer antigens than older versions despite protecting against more diseases. Studies show no increased infection rates in vaccinated children—vaccines strengthen, not weaken, immunity.
Vaccines cause autism
What the evidence shows: This thoroughly debunked claim originated from a fraudulent 1998 study. Multiple large-scale studies involving millions of children have found no association between vaccines and autism. The original study was retracted and its author lost his medical license. Vaccines are safe and essential.
Behaviors
Family Meal Frequency and Obesity Risk: Systematic Review and Meta-Analysis
This meta-analysis synthesized 45 studies examining the relationship between family meal frequency and childhood obesity. Children who shared regular family meals had significantly lower obesity risk and healthier eating patterns.
Key findings: (1) 3+ family meals/week associated with 12% lower overweight/obesity; (2) Higher fruit/vegetable intake and lower fast food consumption; (3) Protective effect independent of family structure or income.
Encourage family meals as part of healthy lifestyle counseling. Even a few shared meals per week make a difference. Focus on the ritual and connection, not just nutrition.
Genetics
Gene Therapy Shows Promise for Spinal Muscular Atrophy Type 1
Long-term follow-up data from the Phase 3 clinical trial of onasemnogene abeparvovec gene therapy reveals sustained motor milestone achievements in children with SMA Type 1 treated before 6 months of age. At 5-year follow-up, 94% of early-treated patients maintained the ability to sit independently, and 68% achieved independent walking—outcomes historically unprecedented in untreated SMA Type 1.
The study also reports on safety outcomes, with no new treatment-related serious adverse events emerging after year 2. These results strengthen the case for newborn screening and early intervention in SMA.
This data reinforces the critical importance of early diagnosis and treatment in SMA. Support newborn screening initiatives in your state. For families with SMA history, discuss carrier testing and ensure rapid referral to neuromuscular specialists if symptoms arise.